UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

First line Immunotherapy for Non-Small Cell Lung Cancer

Pharmaceuticals (Basel, Switzerland), 2020-11, Vol.13 (11), p.373

2020

Volltextzugriff (PDF)

Potential Mechanisms of Cancer-Related Hypercoagulability

Cancers, 2020-02, Vol.12 (3), p.566

2020

Volltextzugriff (PDF)

Applicator for cervical brachytherapy for MRI or CT guided therapy

Technical innovations & patient support in radiation oncology, 2021-12, Vol.20, p.23-27

Nasser, Nicola J.

2021

Volltextzugriff (PDF)

Inferior Vena Cava Filter Usage, Complications, and Retrieval Rate in Cancer Patients

The American journal of medicine, 2014-11, Vol.127 (11), p.1111-1117

2014

Volltextzugriff (PDF)

Maintaining consistent bladder filling during external beam radiotherapy for prostate cancer

Technical innovations & patient support in radiation oncology, 2021-03, Vol.17, p.1-4

2021

Volltextzugriff (PDF)

Edoxaban for Cancer-Associated Venous Thromboembolism

The New England journal of medicine, 2018-07, Vol.379 (1), p.94

Nasser, Nicola J

2018

Volltextzugriff (PDF)

Androgen Flare after LHRH Initiation Is the Side Effect That Makes Most of the Beneficial Effect When It Coincides with Radiation Therapy for Prostate Cancer

Cancers, 2022-04, Vol.14 (8), p.1959

Nasser, Nicola J

2022

Volltextzugriff (PDF)

Markers of Toxicity and Response to Radiation Therapy in Patients With Prostate Cancer

Advances in radiation oncology, 2021-01, Vol.6 (1), p.100603, Article 100603

2021

Volltextzugriff (PDF)

Automatic localization of the prostatic urethra for image guided radiation therapy

Technical innovations & patient support in radiation oncology, 2021-09, Vol.19, p.1-6

2021

Volltextzugriff (PDF)

Control charts for evaluation of quality of low-dose-rate brachytherapy for prostate cancer

Journal of contemporary brachytherapy, 2022-01, Vol.14 (4), p.354-363

2022

Volltextzugriff (PDF)

Splice Variant of Spalax Heparanase Skipping Exon 12

Genes, 2024-08, Vol.15 (8), p.1039

2024

Volltextzugriff (PDF)

Alternatively Spliced Spalax Heparanase Inhibits Extracellular Matrix Degradation, Tumor Growth, and Metastasis

Proceedings of the National Academy of Sciences - PNAS, 2009-02, Vol.106 (7), p.2253-2258

2009

Volltextzugriff (PDF)

Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients

NPJ breast cancer, 2017-03, Vol.3 (1), p.10-5, Article 10

2017

Volltextzugriff (PDF)

Phase II study of concurrent capecitabine and external beam radiotherapy for pain control of bone metastases of breast cancer origin

PloS one, 2013-07, Vol.8 (7), p.e68327

2013

Volltextzugriff (PDF)

Cloning of two splice variants of Spalax heparanase encoding for truncated proteins

Anti-cancer drugs, 2020-10, Vol.31 (9), p.885-889

2020

Volltextzugriff (PDF)

Edoxaban for Cancer-Associated Venous Thromboembolism

The New England journal of medicine, 2018-07, Vol.379 (1), p.93-96

2018

Volltextzugriff (PDF)

Lipid profile and serum characteristics of the blind subterranean mole rat, Spalax

PloS one, 2009-02, Vol.4 (2), p.e4528-e4528

2009

Volltextzugriff (PDF)

Human tissue Kallikreins: Blood levels and response to radiotherapy in intermediate risk prostate cancer

Radiotherapy and oncology, 2017-09, Vol.124 (3), p.427-432

2017

Volltextzugriff (PDF)

Administering Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer 1-6 Days Compared to More Than 14 Days after the Start of LHRH Agonist Is Associated with Better Clinical Outcomes Due to Androgen Flare

Cancers, 2022-02, Vol.14 (4), p.864

2022

Volltextzugriff (PDF)

Adaptive Evolution of Heparanase in Hypoxia-Tolerant Spalax: Gene Cloning and Identification of a Unique Splice Variant

Proceedings of the National Academy of Sciences - PNAS, 2005-10, Vol.102 (42), p.15161-15166

2005

Volltextzugriff (PDF)

Inter-institutional analysis demonstrates the importance of lower than previously anticipated dose regions to prevent late rectal bleeding following prostate radiotherapy

Radiotherapy and oncology, 2018-04, Vol.127 (1), p.88-95

2018

Volltextzugriff (PDF)

Predictors of prostate bed recurrence on magnetic resonance imaging in patients with rising prostate-specific antigen after radical prostatectomy

Canadian Urological Association journal, 2021-01, Vol.15 (1), p.E22-E28

2021

Volltextzugriff (PDF)

Molecular Predictors of Response to Neoadjuvant Chemoradiation for Rectal Cancer

American journal of clinical oncology, 2018-06, Vol.41 (6), p.613-618

2018

Volltextzugriff (PDF)

Sector analysis of dosimetry of prostate cancer patients treated with low-dose-rate brachytherapy

Brachytherapy, 2014-07, Vol.13 (4), p.369-374

2014

Volltextzugriff (PDF)

Pharmacokinetics of low molecular weight heparin in patients with malignant tumors

Anti-cancer drugs, 2015-01, Vol.26 (1), p.106-111

2015

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(42)
Humans
(33)
Oncology
(17)
Aged
(15)
Cancer
(13)
Male
(13)
Middle Aged
(13)
General & Internal Medicine
(10)
Female
(9)
Medicine
(9)
Radiology, Nuclear Medicine & Medical Imaging
(9)
Patients
(8)
Prostate Cancer
(8)
Angiogenesis
(7)
Animals
(7)
Human Health Sciences
(7)
Medicine & Public Health
(7)
Metastasis
(7)
Radiology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

First line Immunotherapy for Non-Small Cell Lung Cancer

Potential Mechanisms of Cancer-Related Hypercoagulability

Applicator for cervical brachytherapy for MRI or CT guided therapy

Inferior Vena Cava Filter Usage, Complications, and Retrieval Rate in Cancer Patients

Maintaining consistent bladder filling during external beam radiotherapy for prostate cancer

Edoxaban for Cancer-Associated Venous Thromboembolism

Androgen Flare after LHRH Initiation Is the Side Effect That Makes Most of the Beneficial Effect When It Coincides with Radiation Therapy for Prostate Cancer

Markers of Toxicity and Response to Radiation Therapy in Patients With Prostate Cancer

Automatic localization of the prostatic urethra for image guided radiation therapy

Control charts for evaluation of quality of low-dose-rate brachytherapy for prostate cancer

Splice Variant of Spalax Heparanase Skipping Exon 12

Alternatively Spliced Spalax Heparanase Inhibits Extracellular Matrix Degradation, Tumor Growth, and Metastasis

Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients

Phase II study of concurrent capecitabine and external beam radiotherapy for pain control of bone metastases of breast cancer origin

Cloning of two splice variants of Spalax heparanase encoding for truncated proteins

Edoxaban for Cancer-Associated Venous Thromboembolism

Lipid profile and serum characteristics of the blind subterranean mole rat, Spalax

Human tissue Kallikreins: Blood levels and response to radiotherapy in intermediate risk prostate cancer

Administering Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer 1-6 Days Compared to More Than 14 Days after the Start of LHRH Agonist Is Associated with Better Clinical Outcomes Due to Androgen Flare

Adaptive Evolution of Heparanase in Hypoxia-Tolerant Spalax: Gene Cloning and Identification of a Unique Splice Variant

Inter-institutional analysis demonstrates the importance of lower than previously anticipated dose regions to prevent late rectal bleeding following prostate radiotherapy

Predictors of prostate bed recurrence on magnetic resonance imaging in patients with rising prostate-specific antigen after radical prostatectomy

Molecular Predictors of Response to Neoadjuvant Chemoradiation for Rectal Cancer

Sector analysis of dosimetry of prostate cancer patients treated with low-dose-rate brachytherapy

Pharmacokinetics of low molecular weight heparin in patients with malignant tumors

Suchergebnisse filtern